# Precigen (PGEN) — News

PGEN · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/pgen/news

## Recent headlines

- [Precigen's Adenoverse gets FDA platform technology designation](https://www.ainvest.com/news/precigen-adenoverse-fda-platform-technology-designation-2609) — AInvest Wire, Sep 21, 2026
  Precigen Inc. has received the FDA’s platform technology designation for its Adenoverse platform, a development that could streamline the regulatory pathway for future gene therapy products built on this technology. The platform technology designation is part of the FDA’s initiative to encourage…
- [Precigen, Inc.: H.C. Wainwright raises target price to $18 from $14](https://www.ainvest.com/news/precigen-wainwright-raises-target-price-18-14-2608) — AInvest Wire, Aug 5, 2026
- [Precigen Q2 revenue USD 54.978 million](https://www.ainvest.com/news/precigen-q2-revenue-usd-54-978-million-2608) — AInvest Wire, Aug 4, 2026
- [Precigen Q2 EPS USD 0.05](https://www.ainvest.com/news/precigen-q2-eps-usd-0-05-2608) — AInvest Wire, Aug 4, 2026
- [Precigen 2Q revenue $55.0M, estimate $27.8M](https://www.ainvest.com/news/precigen-2q-revenue-55-0m-estimate-27-8m-2608) — AInvest Wire, Aug 4, 2026

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).